After Amylyx ALS trial failure, patients share disappointment and fear — but some hope
The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients
The news last week that a Phase 3 trial of Amylyx Pharmaceuticals’ amyotrophic lateral sclerosis drug — marketed as Relyvrio — failed to benefit patients
WASHINGTON — President Biden on Monday unveiled his requests for the 2025 budget, potentially his last chance to cement a legacy on drug costs, cancer
More than 20 million Americans undergo colonoscopy screenings every year, and in many of those cases, doctors end up removing polyps that are 2 cm
Steward Health Care’s Massachusetts hospitals are on the brink of financial disaster. But in many important ways, Steward’s troubles are just a symptom of a
People with depression face an increased risk of cardiovascular disease (CVD); however, more women experience CVD following a depression diagnosis than men, according to a
What You Should Know: – GE HealthCare and Mass General Brigham, longstanding partners in artificial intelligence (AI) research, have announced a new initiative focused on
What You Should Know: Cromwell Hospital has become the first hospital in the UK and Europe to use the Apple Vision Pro, a spatial computing device, as a
What You Should Know: – Frazier Healthcare Partners, a leading healthcare investment firm, announced today the successful acquisition of RevSpring. – RevSpring, a provider of
What You Should Know: – Innovaccer, a healthcare IT company, announced today the acquisition of Pharmacy Quality Solutions (PQS), a leader in Pharmacy-Payer performance technology.
What You Should Know: Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an expanded collaboration with Amazon Web Services